Recon: Boehringer will sell Humira biosimilar at deep discount; WHO recommends second malaria vaccine

ReconReconAdvanced therapies/cell and gene therapyAfricaAPIsAsiaBiologics/ biosimilars/ vaccinesBiotechnologyCanadaCombination products/companion diagnosticsCosmeticsDiagnostics/IVDsDigital health/SaMD/AIEuropeGenericsGlobalLatin America/CaribbeanMedical DevicesMiddle EastNorth AmericaNutritional/Natural HealthOceaniaOTCOtherPharmaceuticalsRegulatory Intelligence/PolicyUnited States